teckro. Revenue and Competitors
Estimated Revenue & Valuation
- teckro.'s estimated annual revenue is currently $26M per year.
- teckro. received $25.0M in venture funding in February 2019.
- teckro.'s estimated revenue per employee is $155,875
- teckro.'s total funding is $66M.
Employee Data
- teckro. has 167 Employees.
- teckro. grew their employee count by -3% last year.
teckro. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.9M | 42 | -2% | N/A | N/A |
#2 | $28.2M | 177 | 14% | N/A | N/A |
#3 | $217M | 1069 | 73% | N/A | N/A |
#4 | $107.8M | 595 | 0% | N/A | N/A |
#5 | $25.5M | 160 | -10% | N/A | N/A |
#6 | $42.4M | 266 | 6% | N/A | N/A |
#7 | $26M | 167 | -3% | $66M | N/A |
#8 | $24.2M | 152 | 6% | N/A | N/A |
#9 | $27.3M | 171 | 31% | N/A | N/A |
#10 | $45.2M | 290 | 8% | $45.4M | N/A |
What Is teckro.?
Clinical research impacts every one of us. In modern healthcare, everything is made possible through clinical research and development. But due to resource-intensive and costly processes, it has become increasingly difficult for clinical trials to sustain support, and be efficiently managed to completion. At Teckro, we are rethinking every element of clinical research - the people, the processes, the technologies used. By making it possible for all relevant information to be instantly accessible to every active member of a clinical trial and for the entire study teams to be connected effortlessly, we are broadening the possibilities of what they can achieve. This means drugs and treatments for the world's most complex diseases are being developed quicker, and our long-term goal of continuously improving healthcare for everyone is realised.
keywords:Healthcare,Pharmaceuticals$66M
Total Funding
167
Number of Employees
$26M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
teckro. News
Teckro, a Limerick, Ireland-based healthcare startup, raised $25m (£19.5m) in Series C funding. The round, which brought total funding raised to date to $43m, was led by Northpond Ventures, Founders Fund, Sands Capital Ventures, Section 32, and Borealis Ventures. The company intends to use the ...
Teckro, an NYC-based technology platform that makes the conduct of clinical trials simple, more transparent and more inclusive for doctors, research nurses and patients announced it has raised $25 million in funding. The Series C funding round was led by Northpond Ventures with participation fro ...
Limerick-founded Teckro has landed $25 million in a Series C funding round led by Northpond Ventures, with participation from Founders Fund, Sands Capital Ventures, Section 32, and Borealis Ventures. The total amount of funding secured by the company to date stands at $43 million. Teckro applie ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 215 | N/A | N/A |
#2 | N/A | 230 | 49% | N/A |
#3 | $36M | 232 | 12% | N/A |
#4 | $36.7M | 237 | N/A | N/A |
#5 | $45.2M | 290 | 8% | $45.4M |
teckro. Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2016-08-09 | $6.0M | Undisclosed | Founders Fund | Article |
2017-09-01 | $10.0M | B | Google Ventures | Article |
2019-02-15 | $25.0M | C | Northpond Ventures | Article |
teckro. Executives
Name | Title |
---|---|
Gary Hughes | CEO/Co-Founder |
Brendan Buckley | CMO |
Jacek Skrzypiec | Chief Technology Officer & Co-Founder |
John Sexton | CFO |
Erik Pineiro | Chief Financial Officer |
Kelly Brown | Chief Marketing Officer |
Brendan Buckley | Chief Medical Officer |
Neil Flanagan | VP of Engineering |
Sandra Blaser | VP of Customer Success |
Ashley Parish | Sr. VP, Strategic Alliances |
Brian Sharkey | VP, Global Solution Engineering |
Marco Nuti | VP, Sales Operation and Development |
Anita Callan | VP of Product |
Kate Penn | Vice President of Quality Management |
Sandra Blaser | Vice President, Services & Customer Success @Teckro |